Recurrent pericarditis occurs in one fifth of patients with systemic lupus erythematosus, with higher rates being observed in ...

Adding obinutuzumab to standard therapy for active lupus nephritis led to significantly higher rates of complete renal ...

Thalidomide shows promise as a steroid-sparing option for IgG4-related disease, with a significant reduction in relapse rates ...

The following is a summary of “Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis,” published in the February 2025 ...

A significant number of Americans experience chronic inflammatory skin conditions with no pinpointed cause and often no ...

The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.

Vincent van der Voort was scheduled to be in action last week at the World Seniors Darts Championship. However, a gout attack forced him to miss out and his first-round opponent, Neil Duff, was ...

Around 21 million adults in the U.S. (8.4%) experienced a major depressive episode in 2023 and Medicare Part B recipients are ...

In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.